Elise Pepermans
CEO & Co-founder
ImmuneSpec
Niel, Belgium
Elise is CEO of ImmuneSpec. Get in touch if you want to find targets for immunotherapy (neoantigens), develop best-in-class Vaccines or biotherapeutics
My organisation
About me
Elise Pepermans obtained her PhD in Biochemistry in the Pasteur Institut in Paris. During her post-doc in the Center for Proteomics (University of Antwerp/Flemish Institut for Technological Research) she developed an optimized workflow for advanced immunopeptidomics. Since March 2023, she is one of the co-founders of ImmuneSpec, an advanced immunopeptidomics platform that offers high-sensitive immunopeptidomics as a service, thereby making this technique available to all biotech companies and researchers.
My organisation
ImmuneSpec is a biotech service provider that offers high-sensitive immunopeptidomics/MAPPS/ligandomics analysis as a service. With our analysis we can identify maximized numbers of MHC I and MHC II associated peptides like neoantigens, tumor associated antigens (for development of immunotherapeutics & PM) but also pathogen derived antigens (for development of prophylactic vaccines) from biological samples. In the context of immunogenicity risk assessment we can deciphere potential T cell epitopes from biotherapeutics for the selection of safe, high efficacy biotherapeutics.
Skills
- immunopeptidomics
- ligandomics
- antigen discovery
- Mass Spectrometry
- immunotherapy
- R&D
- vaccine development
- target selection
Additional questions
How would you categorise yourself?
Organisation Type
Areas of expertise
Therapeutic areas